You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu

News

Green light for cancer drugs developed by AI specialist Owkin

AI biotech company Owkin has announced that two first-in-class rapid, affordable AI-based diagnostic solutions – designed to improve outcomes for patients with breast cancer and colorectal cancer – have been approved for use in Europe.